List of Studies ( Metabolite:GM1 34:1;O2)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004217 | AN007016 | Lipid Alterations in ASAH1-Deficient Cells: Insights into Ceramide Accumulation and Lysosomal Dysfunction | Cultured cells | Human | Metabolic disease | Harvard Medical School | LC-MS |
| ST004163 | AN006910 | Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function | Cultured cells | Human | Metabolic disease | Denali Therapeutics | LC-MS |
| ST004163 | AN006910 | Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function | Cultured cells | Human | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST004059 | AN006716 | Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice | Brain | Mouse | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004059 | AN006716 | Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice | Brain | Mouse | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST003664 | AN006021 | Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function. | T-cells | Mouse | Cancer | University of Chicago | LC-MS |
| ST002505 | AN004127 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | LC-MS |
| ST000114 | AN000192 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | B-cells | Human | Cancer | University of Kentucky | GC-MS/LC-MS |
